Impact of Raised CRP in Mortality and Morbidity among Neonatal Intestinal Obstruction Cases
DOI:
https://doi.org/10.61561/ssbgjms.v6i01.78Keywords:
Neonatal intestinal obstruction, C-reactive protein (CRP), Predictive markerAbstract
Background: Neonatal intestinal obstruction is a grave reason for morbidity and mortality. C-reactive protein (CRP), an acute-phase reactant, may have prognostic implications in predicting the outcome in such patients. This research aimed to identify whether there was any relationship between admission CRP and clinical outcome in neonates presenting with intestinal obstruction.
Materials and Methods: The retrospective observational study examined 80 neonates (0-28 days) with intestinal obstruction over a 12-month period. Admission CRP values were categorized as normal (<6 mg/L), mildly elevated (6-15 mg/L), moderately elevated (16-30 mg/L), and highly elevated (>30 mg/L). The primary outcomes were mortality and morbidity. Statistical analysis included frequency distributions and Chi-square tests with p<0.05 as the significance level.
Results: Out of the study population (60% male), 31.25% were preterm neonates and 27.5% were of low birth weight. The intestinal obstruction was congenital in 56.25% and acquired in 43.75%. CRP values were normal in 31.25%, slightly raised in 18.75%, moderately raised in 20%, and extremely raised in 30% of the neonates. Increasing CRP values were associated with mortality (20% in normal versus 35% in highly elevated groups, p=0.02). Moreover, morbidity also rose with increased CRP (32% normals vs. 50% high raised groups, p=0.01). Combined mortality or morbidity was observed in 85% neonates with high raised CRP compared to 52% normal CRP.
Conclusion: Elevated CRP, particularly when moderately or significantly elevated, is highly associated with increased mortality and morbidity in neonates with intestinal obstruction. Measurement of CRP upon admission can be a valuable predictive marker for risk stratification and clinical management in this high-risk population.
References
1. Puri P, Höllwarth ME, editors. Pediatric Surgery: Diagnosis and Management. Berlin: Springer; 2019. p. 405-14.
2. Juang D, Snyder CL. Neonatal bowel obstruction. Surg Clin North Am. 2012;92(3):685-711.
3. Kimura K, Loening-Baucke V. Bilious vomiting in the newborn: rapid diagnosis of intestinal obstruction. Am Fam Physician. 2000;61(9):2791-8.
4. Ekenze SO, Ajuzieogu OV, Nwomeh BC. Challenges of management and outcome of neonatal surgery in Africa: a systematic review. Pediatr Surg Int. 2016;32(3):291-9.
5. Burjonrappa SC, Crete E, Bouchard S. Prognostic factors in jejuno-ileal atresia. Pediatr Surg Int. 2009;25(9):795-8.
6. Tiwari C, Sandlas G, Jayaswal S, Shah H. Serum C-reactive protein in intestinal obstruction: a predictor of early postoperative recovery. J Pediatr Surg. 2017;52(10):1787-90.
7. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-12.
8. Hofer N, Zacharias E, Müller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology. 2012;102(1):25-36.
9. Chiesa C, Natale F, Pascone R, Osborn JF, Pacifico L, Bonci E, et al. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta. 2011;412(11-12):1053-9.
10. Zea-Vera A, Ochoa TJ. Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr. 2015;61(1):1-13.
11. Sharma D, Farahbakhsh N, Sharma S, Sharma P, Sharma A. Biomarkers for diagnosis of neonatal sepsis: a literature review. J Matern Fetal Neonatal Med. 2018;31(12):1646-59.
12. Hajibandeh S, Hajibandeh S, Hobbs N, Mansour M. Neutrophil-to-lymphocyte ratio predicts acute appendicitis and distinguishes between complicated and uncomplicated appendicitis: a systematic review and meta-analysis. Am J Surg. 2020;219(1):154-63.
13. Seleem MI, Alasiri MM, El-Sayed AA, Alshahrani MY, Zaghloul A. Utility of C-reactive protein and Procalcitonin as Biomarkers for Prediction of Post-Operative Complications Following Major Abdominal Surgery: A Retrospective Study. Ann Med Surg (Lond). 2021;64:102211.
14. Saha AK, Ali MB, Biswas SK, Sharif MM, Azim A. Neonatal intestinal obstruction: patterns, problems and outcome. Bangladesh Med J. 2018;45(1):6-10.
15. Bethell GS, Long AM, Knight M, Hall NJ. Congenital duodenal obstruction in the UK: a population-based study. Arch Dis Child Fetal Neonatal Ed. 2020;105(2):178-83.
16. Ademuyiwa AO, Sowande OA, Ijaduola TK, Adejuyigbe O. Determinants of mortality in neonatal intestinal obstruction in Ile Ife, Nigeria. Afr J Paediatr Surg. 2009;6(1):11-3.
17. Aydemir C, Aydemir H, Kokturk F, Kulah C, Mungan AG. The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis. BMC Pediatr. 2018;18(1):253.
18. Wang X, Sun Y, Shao X. Predictive value of procalcitonin for infection of patients with type-II respiratory failure. Medicine (Baltimore). 2019;98(3):e14232.
19. Cetinkaya M, Ozkan H, Köksal N, Celebi S, Hacimustafaoğlu M. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. J Perinatol. 2009;29(3):225-31.
20. Aslan A, Karaveli C, Ogunc D, Elpek GO, Karaguzel G, Melikoglu M. Does nonsteroidal anti-inflammatory drug administration increase bacterial translocation after intestinal obstruction in rats? Ulus Travma Acil Cerrahi Derg. 2008;14(2):91-6.
21. Saha AK, Ali MB, Biswas SK, Sharif MM, Azim A. Neonatal intestinal obstruction: patterns, problems and outcome. Bangladesh Med J. 2018;45(1):6-10.
22. Bethell GS, Long AM, Knight M, Hall NJ. Congenital duodenal obstruction in the UK: a population-based study. Arch Dis Child Fetal Neonatal Ed. 2020;105(2):178-83.
23. Ademuyiwa AO, Sowande OA, Ijaduola TK, Adejuyigbe O. Determinants of mortality in neonatal intestinal obstruction in Ile Ife, Nigeria. Afr J Paediatr Surg. 2009;6(1):11-3.
24. Aydemir C, Aydemir H, Kokturk F, Kulah C, Mungan AG. The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis. BMC Pediatr. 2018;18(1):253.
25. Wang X, Sun Y, Shao X. Predictive value of procalcitonin for infection of patients with type-II respiratory failure. Medicine (Baltimore). 2019;98(3):e14232.
26. Cetinkaya M, Ozkan H, Köksal N, Celebi S, Hacimustafaoğlu M. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. J Perinatol. 2009;29(3):225-31.
27. Aslan A, Karaveli C, Ogunc D, Elpek GO, Karaguzel G, Melikoglu M. Does nonsteroidal anti-inflammatory drug administration increase bacterial translocation after intestinal obstruction in rats? Ulus Travma Acil Cerrahi Derg. 2008;14(2):91-6.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
